DEA schedule
Is oxybutynin chloride a controlled substance?
Federal schedule for oxybutynin chloride from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Oxybutynin chloride is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and oxybutynin chloride is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted oxybutynin chloride?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 115 prescription listings from 41 labelers, none with a DEA schedule |
| DEA controlled substances list | oxybutynin chloride is not on the list |
Oxybutynin Chloride NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0615-8220 | oxybutynin | tablet, film coated, extended release | 10 mg/1 | NCS HealthCare of KY, LLC dba Vangard Labs | None |
| 50090-5353 | oxybutynin | tablet, film coated, extended release | 10 mg/1 | A-S Medication Solutions | None |
| 68382-256 | oxybutynin | tablet, film coated, extended release | 10 mg/1 | Zydus Pharmaceuticals USA Inc. | None |
| 70771-1087 | oxybutynin | tablet, film coated, extended release | 10 mg/1 | Zydus Lifesciences Limited | None |
| 68382-257 | oxybutynin | tablet, film coated, extended release | 15 mg/1 | Zydus Pharmaceuticals USA Inc. | None |
| 70771-1088 | oxybutynin | tablet, film coated, extended release | 15 mg/1 | Zydus Lifesciences Limited | None |
| 0615-8219 | oxybutynin | tablet, film coated, extended release | 5 mg/1 | NCS HealthCare of KY, LLC dba Vangard Labs | None |
| 67296-2335 | oxybutynin | tablet, film coated, extended release | 5 mg/1 | Redpharm Drug | None |
| 68382-255 | oxybutynin | tablet, film coated, extended release | 5 mg/1 | Zydus Pharmaceuticals USA Inc. | None |
| 70771-1086 | oxybutynin | tablet, film coated, extended release | 5 mg/1 | Zydus Lifesciences Limited | None |
| 62135-520 | Oxybutynin Chloride | solution | 5 mg/5mL | Chartwell RX, LLC | None |
| 68999-520 | Oxybutynin Chloride | solution | 5 mg/5mL | Chartwell Governmental & Specialty RX, LLC. | None |
| 17856-0149 | Oxybutynin Chloride | syrup | 5 mg/5mL | ATLANTIC BIOLOGICALS CORP. | None |
| 54838-510 | Oxybutynin Chloride | syrup | 5 mg/5mL | Lannett Company, Inc. | None |
| 52817-261 | Oxybutynin Chloride | tablet | 2.5 mg/1 | TruPharma LLC | None |
| 64380-190 | Oxybutynin Chloride | tablet | 2.5 mg/1 | Strides Pharma Science Limited | None |
| 64980-531 | OXYBUTYNIN CHLORIDE | tablet | 2.5 mg/1 | RISING PHARMA HOLDINGS, INC. | None |
| 64980-734 | OXYBUTYNIN CHLORIDE | tablet | 2.5 mg/1 | RISING PHARMA HOLDINGS, INC. | None |
| 0615-8492 | OXYBUTYNIN CHLORIDE | tablet | 5 mg/1 | NCS HealthCare of KY, LLC dba Vangard Labs | None |
| 0832-0038 | Oxybutynin Chloride | tablet | 5 mg/1 | Upsher-Smith Laboratories, LLC | None |
| 0904-7027 | Oxybutynin Chloride | tablet | 5 mg/1 | Major Pharmaceuticals | None |
| 10702-201 | Oxybutynin Chloride | tablet | 5 mg/1 | KVK-Tech, Inc. | None |
| 23155-810 | Oxybutynin Chloride | tablet | 5 mg/1 | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | None |
| 23155-913 | Oxybutynin Chloride | tablet | 5 mg/1 | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | None |
| 42291-456 | Oxybutynin Chloride | tablet | 5 mg/1 | AvKARE | None |
| 43063-851 | Oxybutynin Chloride | tablet | 5 mg/1 | PD-Rx Pharmaceuticals, Inc. | None |
| 43063-931 | Oxybutynin Chloride | tablet | 5 mg/1 | PD-Rx Pharmaceuticals, Inc. | None |
| 43353-978 | Oxybutynin Chloride | tablet | 5 mg/1 | Aphena Pharma Solutions - Tennessee, LLC | None |
| 50090-4622 | Oxybutynin Chloride | tablet | 5 mg/1 | A-S Medication Solutions | None |
| 50090-6199 | OXYBUTYNIN CHLORIDE | tablet | 5 mg/1 | A-S Medication Solutions | None |
| 50090-6638 | OXYBUTYNIN CHLORIDE | tablet | 5 mg/1 | A-S Medication Solutions | None |
| 50090-6966 | Oxybutynin Chloride | tablet | 5 mg/1 | A-S Medication Solutions | None |
| 50090-6967 | Oxybutynin Chloride | tablet | 5 mg/1 | A-S Medication Solutions | None |
| 50090-7766 | OXYBUTYNIN CHLORIDE | tablet | 5 mg/1 | A-S Medication Solutions | None |
| 50090-8078 | OXYBUTYNIN CHLORIDE | tablet | 5 mg/1 | A-S Medication Solutions | None |
| 50111-456 | Oxybutynin Chloride | tablet | 5 mg/1 | Teva Pharmaceuticals USA, Inc. | None |
| 51407-099 | Oxybutynin Chloride | tablet | 5 mg/1 | Golden State Medical Supply, Inc. | None |
| 51655-665 | Oxybutynin Chloride | tablet | 5 mg/1 | Northwind Health Company, LLC | None |
| 52817-260 | Oxybutynin Chloride | tablet | 5 mg/1 | TruPharma LLC | None |
| 55154-2632 | Oxybutynin Chloride | tablet | 5 mg/1 | Cardinal Health 107, LLC | None |
Showing 40 of 115 listings.
Questions
Is oxybutynin chloride a controlled substance?
No. Oxybutynin chloride is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and oxybutynin chloride is not on the DEA controlled substances list.
Is oxybutynin chloride a narcotic?
No. Oxybutynin chloride is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Cholinergic Muscarinic Antagonist.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Oxybutynin Chloride
- What is Oxybutynin Chloride used for?FDA label uses
- Generic for DitropanFDA Orange Book
- Generic for Ditropan XLFDA Orange Book
- Cholinergic Muscarinic Antagonists listFDA drug class
- NDC 0615-8219Oxybutynin Chloride NDC record
- NDC 0615-8220Oxybutynin Chloride NDC record
- NDC 0615-8492Oxybutynin Chloride NDC record